Works matching AU Kesselheim, Aaron S.

Results: 487

The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study.

Published in:

PLoS Medicine, 2025, v. 22, n. 5, p. 1, doi. 10.1371/journal.pmed.1004596

By:

Demkowicz, Brandon J.;
Rader, Kevin;
Wang, Shirley V.;
Kesselheim, Aaron S.;
Feldman, William B.

Publication type:

Article

Strategies to Advance Drug Repurposing for Rare Diseases.

Published in:

2025

By:

Hong, Dongzhe;
Kesselheim, Aaron S.

Publication type:

Opinion

Does Policy Uncertainty Boost Vaccine Hesitancy? Political Controversy, the FDA, and COVID-19 Vaccine Hesitancy in Fall 2020.

Published in:

Journal of Health Politics, Policy & Law, 2025, v. 50, n. 3, p. 397, doi. 10.1215/03616878-11670184

By:

Carpenter, Daniel;
Dardet, Matthew E.;
Bhaskar, Anushka;
Rand, Leah Z.;
Feldman, William B.;
Kesselheim, Aaron S.

Publication type:

Article

Prescribing systemic steroids for acute respiratory tract infections in United States outpatient settings: A nationwide population-based cohort study.

Published in:

2020

By:

Lin, Kueiyu Joshua;
Dvorin, Evan;
Kesselheim, Aaron S.

Publication type:

journal article

FAIRER RETURNS ON PUBLIC INVESTMENTS.

Published in:

2023

By:

Lalani, Hussain;
Kesselheim, Aaron S.

Publication type:

Letter to the Editor

Regulating genetic research and applications.

Published in:

2016

By:

KOSAL, MARGARET E.;
HEY, SPENCER PHILLIPS;
KESSELHEIM, AARON S.;
BRECKENRIDGE, ALASDAIR

Publication type:

Letter to the Editor

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.

Published in:

Inquiry (00469580), 2022, p. 1, doi. 10.1177/00469580221124821

By:

Amin, Tahir;
Kesselheim, Aaron S.

Publication type:

Article

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.

Published in:

Inquiry (00469580), 2022, v. 59, p. 1, doi. 10.1177/00469580221124821

By:

Amin, Tahir;
Kesselheim, Aaron S.

Publication type:

Article

Association between changes in prices and out‐of‐pocket costs for brand‐name clinician‐administered drugs.

Published in:

Health Services Research, 2024, v. 59, n. 6, p. 1, doi. 10.1111/1475-6773.14279

By:

Lalani, Hussain S.;
Russo, Massimilano;
Desai, Rishi J.;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

Article

Market dynamics of authorized generics in Medicaid from 2014 to 2020.

Published in:

Health Services Research, 2023, v. 58, n. 4, p. 953, doi. 10.1111/1475-6773.14145

By:

Rome, Benjamin N.;
Gunter, Simon J.;
Kesselheim, Aaron S.

Publication type:

Article

Alternatives to the quality‐adjusted life year: How well do they address common criticisms?

Published in:

Health Services Research, 2023, v. 58, n. 2, p. 433, doi. 10.1111/1475-6773.14116

By:

Rand, Leah Z.;
Melendez‐Torres, G. J.;
Kesselheim, Aaron S.

Publication type:

Article

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply.

Published in:

Hastings Center Report, 2024, v. 54, n. 2, p. 44, doi. 10.1002/hast.1579

By:

Rand, Leah Z.;
Carpenter, Daniel P.;
Kesselheim, Aaron S.;
Bhaskar, Anushka;
Darrow, Jonathan J.;
Feldman, William B.

Publication type:

Article

Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.

Published in:

Hastings Center Report, 2023, v. 53, p. S60, doi. 10.1002/hast.1525

By:

Rand, Leah Z.;
Carpenter, Daniel P.;
Kesselheim, Aaron S.;
Bhaskar, Anushka;
Darrow, Jonathan J.;
Feldman, William B.

Publication type:

Article

The Real-World Ethics of Adaptive-Design Clinical Trials.

Published in:

Hastings Center Report, 2017, v. 47, n. 6, p. 27, doi. 10.1002/hast.783

By:

Bothwell, Laura E.;
Kesselheim, Aaron S.

Publication type:

Article

Reprioritizing Research Activity for the Post-Antibiotic Era: Ethical, Legal, and Social Considerations.

Published in:

Hastings Center Report, 2017, v. 47, n. 2, p. 16, doi. 10.1002/hast.685

By:

Hey, Spencer Phillips;
Kesselheim, Aaron S.

Publication type:

Article

Trends in Medicare Part D Inhaler Spending: 2012-2018.

Published in:

2021

By:

Feldman, William B;
Gagne, Joshua J;
Kesselheim, Aaron S

Publication type:

Letter

Trends in Medicare Part D Inhaler Spending: 2012–2018.

Published in:

Annals of the American Thoracic Society, 2021, v. 18, n. 3, p. 445

By:

Feldman, William B.;
Gagne, Joshua J.;
Kesselheim, Aaron S.

Publication type:

Article

Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis.

Published in:

JAMA Neurology, 2024, v. 81, n. 1, p. 85, doi. 10.1001/jamaneurol.2023.4514

By:

Kim, John;
Kesselheim, Aaron S.;
Bove, Riley;
Avorn, Jerry;
Rome, Benjamin N.

Publication type:

Article

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants.

Published in:

JAMA Internal Medicine, 2025, v. 185, n. 4, p. 431, doi. 10.1001/jamainternmed.2024.8335

By:

Quinlan, Claire M.;
Avorn, Jerry;
Kesselheim, Aaron S.;
Singer, Daniel E.;
Zhang, Yichi;
Cervone, Alex;
Lin, Kueiyu Joshua

Publication type:

Article

Estimated Savings Under the Medicare High-Value Drug List Model.

Published in:

JAMA Internal Medicine, 2024, v. 184, n. 11, p. 1390, doi. 10.1001/jamainternmed.2024.4846

By:

Cai, Christopher L.;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

Article

Patent Portfolios Protecting 10 Top-Selling Prescription Drugs.

Published in:

JAMA Internal Medicine, 2024, v. 184, n. 7, p. 810, doi. 10.1001/jamainternmed.2024.0836

By:

Horrow, Caroline;
Gabriele, Sarah M.E.;
Tu, S. Sean;
Sarpatwari, Ameet;
Kesselheim, Aaron S.

Publication type:

Article

Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.

Published in:

JAMA Internal Medicine, 2024, v. 184, n. 1, p. 63, doi. 10.1001/jamainternmed.2023.6293

By:

Vogel, Matthew;
Zhao, Olivia;
Feldman, William B.;
Chandra, Amitabh;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

Article

Why Some Patients Overpay for Specialty Generic Drugs.

Published in:

2024

By:

Crosson, Francis J.;
Kesselheim, Aaron S.

Publication type:

Opinion

Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.

Published in:

JAMA Internal Medicine, 2023, v. 183, n. 9, p. 999, doi. 10.1001/jamainternmed.2023.3961

By:

Daval, C. Joseph Ross;
Kesselheim, Aaron S.

Publication type:

Article

Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.

Published in:

JAMA Internal Medicine, 2023, v. 183, n. 7, p. 685, doi. 10.1001/jamainternmed.2023.1245

By:

Feldman, William B.;
Avorn, Jerry;
Kesselheim, Aaron S.;
Gagne, Joshua J.

Publication type:

Article

Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021.

Published in:

JAMA Internal Medicine, 2023, v. 183, n. 3, p. 275, doi. 10.1001/jamainternmed.2022.6299

By:

Wang, Junyi;
Lee, ChangWon C.;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

Article

Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings.

Published in:

2023

By:

Egilman, Alexander C.;
Van de Wiele, Victor L.;
Rome, Benjamin N.;
Darrow, Jonathan J.;
Tu, S. Sean;
Kesselheim, Aaron S.;
Sarpatwari, Ameet

Publication type:

journal article

Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers.

Published in:

2022

By:

Daval, C. Joseph Ross;
Avorn, Jerry;
Kesselheim, Aaron S.

Publication type:

journal article

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016.

Published in:

2022

By:

Brown, Beatrice L.;
Mitra-Majumdar, Mayookha;
Darrow, Jonathan J.;
Moneer, Osman;
Pham, Catherine;
Avorn, Jerry;
Kesselheim, Aaron S.

Publication type:

journal article

What to Know About the Alzheimer Drug Aducanumab (Aduhelm).

Published in:

2022

By:

Woloshin, Steven;
Kesselheim, Aaron S.

Publication type:

journal article

Extending Drug Monopolies by Patenting Safe Drug Use.

Published in:

2022

By:

Bloomfield, Doni;
Walsh, Bryan S.;
Kesselheim, Aaron S.

Publication type:

journal article

Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020.

Published in:

2022

By:

Gunter, Simon J.;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

journal article

New Treatments for Migraine-Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe.

Published in:

2022

By:

Hwang, Thomas J.;
Vokinger, Kerstin N.;
Kesselheim, Aaron S.

Publication type:

journal article

Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.

Published in:

2022

By:

Feldman, William B.;
Rome, Benjamin N.;
Brown, Beatrice L.;
Kesselheim, Aaron S.

Publication type:

journal article

Public-sector Contributions to Novel Biologic Drugs.

Published in:

2021

By:

Nayak, Rahul K.;
Lee, ChangWon C.;
Avorn, Jerry;
Kesselheim, Aaron S.

Publication type:

journal article

Fulfilling the Mandate of the US Food and Drug Administration's Accelerated Approval Pathway: The Need for Reforms.

Published in:

2021

By:

Gyawali, Bishal;
Ross, Joseph S.;
Kesselheim, Aaron S.

Publication type:

journal article

Will Ending the Medicaid Drug Rebate Cap Lower Drug Prices?

Published in:

2021

By:

Rome, Benjamin N.;
Kesselheim, Aaron S.

Publication type:

journal article

Market Exclusivity and Changes in Competition and Prices Associated With the US Food and Drug Administration Unapproved Drug Initiative.

Published in:

2021

By:

Gunter, Simon J.;
Kesselheim, Aaron S.;
Rome, Benjamin N.

Publication type:

journal article

Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling.

Published in:

2021

By:

Gyawali, Bishal;
Darrow, Jonathan J.;
Kesselheim, Aaron S.

Publication type:

journal article

Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.

Published in:

2021

By:

Walsh, Bryan S.;
Sarpatwari, Ameet;
Rome, Benjamin N.;
Kesselheim, Aaron S.

Publication type:

journal article

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.

Published in:

2021

By:

Cherla, Avi;
Naci, Huseyin;
Kesselheim, Aaron S.;
Gyawali, Bishal;
Mossialos, Elias

Publication type:

journal article

Substitution of Generic Drugs and Biosimilars-Reply.

Published in:

2021

By:

Sarpatwari, Ameet;
Kesselheim, Aaron S.;
Sacks, Chana A.

Publication type:

journal article

Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Published in:

2021

By:

Sacks, Chana A.;
Van de Wiele, Victor L.;
Fulchino, Lisa A.;
Patel, Lajja;
Kesselheim, Aaron S.;
Sarpatwari, Ameet

Publication type:

journal article

Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies.

Published in:

2020

By:

Zhai, Mike Z.;
Lye, Carolyn T.;
Kesselheim, Aaron S.

Publication type:

journal article

US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.

Published in:

2020

By:

Rome, Benjamin N.;
Tessema, Frazer A.;
Kesselheim, Aaron S.

Publication type:

journal article

Internet Searches for Unproven COVID-19 Therapies in the United States.

Published in:

2020

By:

Liu, Michael;
Caputi, Theodore L.;
Dredze, Mark;
Kesselheim, Aaron S.;
Ayers, John W.

Publication type:

Letter

Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.

Published in:

2020

By:

Feldman, William B.;
Rome, Benjamin N.;
Lehmann, Lisa Soleymani;
Kesselheim, Aaron S.

Publication type:

journal article

Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary.

Published in:

2020

By:

Feldman, William B.;
Avorn, Jerry;
Kesselheim, Aaron S.

Publication type:

journal article

Confidentiality Orders and Public Interest in Drug and Medical Device Litigation.

Published in:

2020

By:

Egilman, Alexander C.;
Kesselheim, Aaron S.;
Krumholz, Harlan M.;
Ross, Joseph S.;
Kim, Jeanie;
Kapczynski, Amy

Publication type:

journal article

US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals.

Published in:

2020

By:

Hey, Spencer Phillips;
Kesselheim, Aaron S.;
Patel, Pranav;
Mehrotra, Preeti;
Powers III, John H.;
Powers, John H 3rd

Publication type:

journal article